Literature DB >> 10195068

Augmentation therapy for severe alpha 1-antitrypsin deficiency: is the jury still out on a trial?

J K Stoller.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 10195068      PMCID： PMC1745143          DOI： 10.1136/thx.53.12.1007

Source DB:  PubMed          Journal:  Thorax        ISSN： 0040-6376            Impact factor:   9.139


× No keyword cloud information.
  3 in total

Review 1.  Alpha-1-antitrypsin deficiency: what next?

Authors:  R A Stockley
Journal:  Thorax       Date:  2000-07       Impact factor: 9.139

Review 2.  Augmentation therapy for alpha(1)-antitrypsin deficiency.

Authors:  Georges S Juvelekian; James K Stoller
Journal:  Drugs       Date:  2004       Impact factor: 9.546

Review 3.  Advances in managing COPD related to α1 -antitrypsin deficiency: An under-recognized genetic disorder.

Authors:  Timothy J Craig; Maria Paula Henao
Journal:  Allergy       Date:  2018-07-26       Impact factor: 13.146
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.